Market revenue in 2020 | USD 17.9 billion |
Market revenue in 2028 | USD 58.8 billion |
Growth rate | 16% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 22.91% in 2020. Horizon Databook has segmented the UK biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Growing research on life sciences is driving the UK market. Brexit was expected to impede research in the country, but its contribution in the life sciences domain remains stable. For the 50th year, the UK has continued as the second largest researcher in life sciences.
The country has top institutes, such as the University of Oxford, the University of Cambridge, and Imperial College London, which are key users of kits & reagents. The Oxford biotech cluster supported by the Oxford Biotech Network carries out a broad range of projects, from regular drug discovery & development to research on innovative medical technology.
For instance, in February 2021, CPI declared the launch of a project in Medicine Developing Innovation Center that is focused on revolutionize manufacturing of oligonucleotides, by collaboration with Novartis, AstraZeneca, UK Research & innovation, and Exactmer.
Horizon Databook provides a detailed overview of country-level data and insights on the UK biotechnology reagents & kits market , including forecasts for subscribers. This country databook contains high-level insights into UK biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account